Buy or sell Locanabio stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Locanabio Stock
Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.
About Locanabio Stock
Locanabio, Inc., is an RNA-targeting gene therapy company focused on developing therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.
Funding History
May 2019 | $55.0M |
---|---|
June 2019 | $550K |
December 2020 | $100M |
Management
Scientific Advisory Board Member
Edward Conner
Chairman
Thomas Daniel
Board member
Cayce Denton
SVP of Technical Operations
Adam Fowler
Board Member
Rajul Jain
CSO
Kathie Bishop
CEO
James Burns
Chief Scientific Officer
John Leonard
Vice President of Human Resources
Holly D. Chrzanowski
Chief Financial Officer
Kat Lange
Co-Founder
Gene Yeo
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase